In vitrolipolysis tests on lipid nanoparticles: comparison between lipase/co-lipase and pancreatic extract

Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations

(2014) Niranjan Kathe et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

‘Stealth’ lipid-based formulations: Poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug

(2014) Orlagh M. Feeney et al.   JOURNAL OF CONTROLLED RELEASE

A retinyl palmitate-loaded solid lipid nanoparticle system: Effect of surface modification with dicetyl phosphate on skin permeation in vitro and anti-wrinkle effect in vivo

(2013) Ho Seong Jeon et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam

(2013) Rawia M. Khalil et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

In Vitro Digestion of the Self-Emulsifying Lipid Excipient Labrasol® by Gastrointestinal Lipases and Influence of its Colloidal Structure on Lipolysis Rate

(2013) Sylvie Fernandez et al.   PHARMACEUTICAL RESEARCH

New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles

(2012) Samuel Vidal Mussi et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications

(2012) Evren Gokce et al.   International Journal of Nanomedicine

Influence of particle size on the in vitro digestibility of protein-coated lipid nanoparticles

(2012) Elizabeth Troncoso et al.   JOURNAL OF COLLOID AND INTERFACE SCIENCE

In vitro digestion of curcuminoid-loaded lipid nanoparticles

(2012) Andreas Noack et al.   JOURNAL OF NANOPARTICLE RESEARCH

Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 1: Method Parameterization and Comparison of In Vitro Digestion Profiles Across a Range of Representative Formulations

(2012) Hywel D. Williams et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells

(2012) Jong-Suep Baek et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Toward the Establishment of Standardized in Vitro Tests for Lipid-Based Formulations. 2. The Effect of Bile Salt Concentration and Drug Loading on the Performance of Type I, II, IIIA, IIIB, and IV Formulations during in Vitro Digestion

(2012) Hywel D. Williams et al.   MOLECULAR PHARMACEUTICS

Specific assay of carboxyl ester hydrolase using PEG esters as substrate

(2010) Sylvie Fernandez et al.   Analytical Methods

Chitosan-associated SLN:in vitroandex vivocharacterization of cyclosporine A loaded ophthalmic systems

(2010) Giuseppina Sandri et al.   JOURNAL OF MICROENCAPSULATION

In Vitro Gastrointestinal Lipolysis of Four Formulations of Piroxicam and Cinnarizine with the Self Emulsifying Excipients Labrasol® and Gelucire® 44/14

(2009) Sylvie Fernandez et al.   PHARMACEUTICAL RESEARCH

Lipolysis of the semi-solid self-emulsifying excipient Gelucire® 44/14 by digestive lipases

(2008) Sylvie Fernandez et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery

(2008) Marc Muchow et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Influence of Lipid Physical State on the in Vitro Digestibility of Emulsified Lipids

(2008) Lucile Bonnaire et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY